ARCHIVES

DCT Board Approves Phase 2/3 Studies Of LAK-IL-2

This article is from The Cancer Letter archive.

Vol. 12 No. 07 | February 14, 1986

Download PDF Visit The Full Archive

Related Articles

Longterm Followup Finds Taxotere Improves Survival

January 25, 2008

Utah, Hopkins Get Large Donations To Support Research

October 6, 1995

In Brief: No Such Thing As Premature Data, Fisher Says- Only Immature Evaluation, Premature Application

June 20, 1980

Carter In Last Budget Asks Four Percent Increase For NCI, But Then Seeks $13.5 Million Rescission

January 23, 1981

Bill Planned To Okay Medicare/Medicaid Payment For 100% Of Outpatient Anticancer Drug Costs

February 16, 1979

NCI funds nine centers for $14.9 million integrative biology program.

October 29, 2004